Abraham, W. T., Fisher, W. G., Smith, A. L. et al. Cardiac resynchronization in chronic heart failure. N. Engl. J. Med., 346:1845–53, 2002.
Adams, K. F., Gheorghiade, M., Uretsky, B. F. et al. Clinical benefits of low serum digoxin concentrations in heart failure. J. Am. Coll. Cardiol., 39:946–53, 2002.
Bauersachs, J., Heck, M., Fraccarollo, D., Hildemann, S. K. et al. Additions of spironolactone to angiotensin-converting enzyme inhibi¬tion in heart failure improves endothelial vasomotor dysfunction. J. Am. Coll. Cardiol., 39:351–8, 2002.
Brad, G., Angeja, M. D. and Grossman, W., Evaluation and management of diastolic heart failure. Circulation, 107:659, 2003.
Borbe´ly, A., van der Velden, J., Papp, Z. et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation, 111:774–781, 2005.
Bradley, D. J., Bradley, E. A. Baughman, K. L. et al. Cardiac resynchronization and death from progressive heart failure. A meta-analysis of randomized controlled trials. JAMA, 289:730–740, 2003.
Bursi, F., Enriquez-Sarano, M., Nkomo, V. T. et al. Heart failure and death after myocardial infarction in the community: The emerging role of mitral regurgitation. Circulation, 111:295–301, 2005.
Campbell, D. J. How should I combine beta-blockers, ACE inhibitors and ARBs in the management of heart failure? J. Am. Coll. Cardiol. ACC Curr. J. Rev., May/June, 55–58, 2003.

Страницы: 1 | 2 | 3 | 4 | 5 | 6